Published in Patient Educ Couns on January 17, 2013
Scoping review of patient-centered care approaches in healthcare. BMC Health Serv Res (2014) 1.03
Older adults receiving assistance with physician visits and prescribed medications and their family caregivers: prevalence, characteristics, and hours of care. J Gerontol B Psychol Sci Soc Sci (2014) 0.98
Decision aids for breast cancer chemoprevention. Breast Cancer Res (2013) 0.96
Survivorship care plans in cancer: a systematic review of care plan outcomes. Br J Cancer (2014) 0.89
Development of the Health Literacy of Caregivers Scale - Cancer (HLCS-C): item generation and content validity testing. BMC Fam Pract (2014) 0.82
What is a good medical decision? A research agenda guided by perspectives from multiple stakeholders. J Behav Med (2016) 0.80
Examining the context and helpfulness of family companion contributions to older adults' primary care visits. Patient Educ Couns (2016) 0.77
Involvement in Decision Making and Satisfaction With Treatment Among Partners of Patients With Newly Diagnosed Localized Prostate Cancer. Oncol Nurs Forum (2015) 0.77
Role and Influence of the Patient's Companion in Family Medicine Consultations: "The Patient's Perspective". J Family Med Prim Care (2013) 0.77
Patients in context: recognizing the companion as part of a patient-centered team. Patient Educ Couns (2013) 0.77
Systematic review of clinical practice guidelines recommendations about primary cardiovascular disease prevention for older adults. BMC Fam Pract (2015) 0.76
Attitudes and experiences of family involvement in cancer consultations: a qualitative exploration of patient and family member perspectives. Support Care Cancer (2016) 0.76
Correlates of family involvement before and during medical visits among older adults with high-risk diabetes. Diabet Med (2016) 0.75
Family caregivers and physicians caring for cancer patients: on-the-job training for all. J Gen Intern Med (2014) 0.75
Health information exchange for patients with intellectual disabilities: a general practice perspective. Br J Gen Pract (2016) 0.75
"Speaking-for" and "speaking-as": pseudo-surrogacy in physician-patient-companion medical encounters about advanced cancer. Patient Educ Couns (2014) 0.75
Role of relatives of ethnic minority patients in patient safety in hospital care: a qualitative study. BMJ Open (2016) 0.75
A Narrative Review of Patient and Family Engagement: The "Foundation" of the Medical "Home". Med Care (2016) 0.75
Family presence and participation during medical visits of heart failure patients: An analysis of survey and audiotaped communication data. Patient Educ Couns (2016) 0.75
Crossing the perspectives of patients, families, and physicians on cancer treatment: A qualitative study. Oncotarget (2016) 0.75
Family Communication, Risk Perception and Cancer Knowledge of Young Adults from BRCA1/2 Families: a Systematic Review. J Genet Couns (2017) 0.75
Information and decision-making needs of psychiatric patients: the perspective of relatives. PeerJ (2017) 0.75
Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med (1997) 19.00
Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med (1999) 10.94
The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation. J Clin Oncol (1995) 6.08
Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell (1994) 5.37
What do we mean by partnership in making decisions about treatment? BMJ (1999) 5.31
A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer. Ann Intern Med (1992) 4.60
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology (1995) 4.39
Controlling health expenditures--the Canadian reality. N Engl J Med (1989) 4.36
The physician-patient encounter: the physician as a perfect agent for the patient versus the informed treatment decision-making model. Soc Sci Med (1998) 4.19
System for Health Area Resource Planning (SHARP): an application to Ontario medical school enrollment. CMAJ (1994) 4.11
Communicating prognosis in early breast cancer: do women understand the language used? Med J Aust (1999) 3.76
Cost effectiveness/utility analyses. Do current decision rules lead us to where we want to be? J Health Econ (1992) 3.33
Quality-adjusted life years, utility theory, and healthy-years equivalents. Med Decis Making (1989) 3.26
Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol (1994) 3.22
Health care contingent valuation studies: a review and classification of the literature. Health Econ (1998) 3.13
The Early External Cephalic Version (ECV) 2 Trial: an international multicentre randomised controlled trial of timing of ECV for breech pregnancies. BJOG (2011) 2.97
Database on the structure of small ribosomal subunit RNA. Nucleic Acids Res (1997) 2.95
Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet (1998) 2.84
The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene (1995) 2.80
Sharing decisions in cancer care. Soc Sci Med (2001) 2.70
Universal precautions to prevent HIV transmission to health care workers: an economic analysis. CMAJ (1990) 2.68
Communication styles in the cancer consultation: preferences for a patient-centred approach. Psychooncology (2000) 2.59
Cost-effectiveness ratios: in a league of their own. Health Policy (1994) 2.55
Needle exchange programs: an economic evaluation of a local experience. CMAJ (1997) 2.46
Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. J Clin Oncol (2001) 2.34
Promoting patient participation and shortening cancer consultations: a randomised trial. Br J Cancer (2001) 2.13
Defining morning stiffness in rheumatoid arthritis. J Rheumatol (1999) 2.12
Communicating prognosis in cancer care: a systematic review of the literature. Ann Oncol (2005) 2.09
Associated injuries in casualties with traumatic lower extremity amputations caused by improvised explosive devices. Br J Surg (2011) 2.04
Lay constructions of decision-making in cancer. Psychooncology (2002) 2.03
The take-home message: patients prefer consultation audiotapes to summary letters. J Clin Oncol (1994) 2.03
On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol (1996) 2.03
Analysis of fluorescence decay curves by means of the Laplace transformation. Biophys J (1975) 1.96
Patients' preferences for therapy in advanced epithelial ovarian cancer: development, testing, and application of a bedside decision instrument. Gynecol Oncol (1996) 1.91
Developing ethical strategies to assist oncologists in seeking informed consent to cancer clinical trials. Soc Sci Med (2004) 1.90
Discounting in the economic evaluation of health care interventions. Med Care (1993) 1.89
Comparison of cervical, urethral, and urine specimens for the detection of Chlamydia trachomatis in women. J Infect Dis (1991) 1.87
Osteoporosis influences the early period of fracture healing in a rat osteoporotic model. Bone (2001) 1.76
Writing to referring doctors after a new patient consultation. What is wanted and what was contained in letters from one medical oncologist? Aust N Z J Med (1995) 1.75
The healthy-years equivalents: how to measure them using the standard gamble approach. Med Decis Making (1991) 1.73
Noninvasive positive pressure ventilation in the setting of severe, acute exacerbations of chronic obstructive pulmonary disease: more effective and less expensive. Crit Care Med (2000) 1.71
Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients. Swiss HIV Cohort Study. AIDS (1999) 1.70
Physician supply in Ontario: further observations on SHARP and the SHARP projections. CMAJ (1995) 1.67
Breast irradiation postlumpectomy: development and evaluation of a decision instrument. J Clin Oncol (1995) 1.66
Shared decision making in a publicly funded health care system. Policies exist to reduce the risk of conflict between individual and society. BMJ (1999) 1.65
Stage-specific expression and genomic organization of the actin genes of the malaria parasite Plasmodium falciparum. Mol Biochem Parasitol (1989) 1.64
Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med (1994) 1.64
Promoting patient participation in the cancer consultation: evaluation of a prompt sheet and coaching in question-asking. Br J Cancer (1999) 1.63
Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J Exp Med (1994) 1.63
Oncologists' reactions to cancer patients' verbal cues. Psychooncology (2002) 1.61
Recognizing diversity in public preferences: the use of preference sub-groups in cost-effectiveness analysis. Health Econ (2001) 1.59
Psychological responses of patients receiving a diagnosis of cancer. Ann Oncol (2003) 1.58
Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect Immun (1994) 1.57
Communicating prognosis to patients with metastatic disease: what do they really want to know? Support Care Cancer (2001) 1.57
How to improve communication between doctors and patients. Learning more about the decision making context is important. BMJ (2000) 1.55
Newborn circumcision: an economic perspective. Can Med Assoc J (1984) 1.54
Frozen section consultation. Utilization patterns and knowledge base of surgical faculty at a university hospital. Am J Clin Pathol (1995) 1.54
When do the "dollars" make sense? Toward a conceptual framework for contingent valuation studies in health care. Med Decis Making (1996) 1.53
The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease. Gut (2002) 1.50
Properties of Clarke's column neurones. Acta Physiol Scand (1969) 1.50
[Heights and weights of Danish children]. Ugeskr Laeger (1982) 1.50
General information tapes inhibit recall of the cancer consultation. J Clin Oncol (1993) 1.47
Is it 'worthwhile' to continue treating patients with a prolonged stay (>14 days) in the ICU? An economic evaluation. Chest (1998) 1.47
Individual correlates of health service utilization and the cost of poor adjustment to chronic illness. Med Care (1990) 1.44
Identifying indicators of colorectal cancer care coordination: a Delphi study. Colorectal Dis (2014) 1.43
[Use of isokinetic techniques vs standard physiotherapy in patients with chronic low back pain. Preliminary results]. Ann Readapt Med Phys (2004) 1.43
Mastectomy or lumpectomy? Helping women make informed choices. J Clin Oncol (1999) 1.42
Preoperative HIV testing: is it less expensive than universal precautions? J Clin Epidemiol (1993) 1.41
Effectiveness and efficiency of selective vs universal screening for chlamydial infection in sexually active young women. Arch Intern Med (1992) 1.41
Long-term care reform in Alberta, Canada. Alberta's resident classification system: fact, fiction and future prospects. J Adv Nurs (1994) 1.40
[Radioiodine therapy for women with Graves' disease and the risk of foetal hypothyroidism if they are later found to be pregnant]. Ned Tijdschr Geneeskd (2006) 1.39
Understanding economic evaluations: a review of the knee arthroplasty literature. Am J Knee Surg (1999) 1.38
Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations. Ann Oncol (2011) 1.36
The supportive care needs of newly diagnosed cancer patients attending a regional cancer center. Cancer (1997) 1.35
Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective. Arch Intern Med (1997) 1.34
Misunderstanding in cancer patients: why shoot the messenger? Ann Oncol (1999) 1.33
Hangman's fracture: arguments in favor of surgical therapy for type II and III according to Edwards and Levine. Surg Neurol (1998) 1.33
Outcomes and costs of coronary artery bypass grafting: comparison between octogenarians and septuagenarians at a tertiary care centre. CMAJ (2001) 1.33
Seeking informed consent to cancer clinical trials: describing current practice. Soc Sci Med (2004) 1.31
Hearing the bad news of a cancer diagnosis: the Australian melanoma patient's perspective. Ann Oncol (2001) 1.30
Chemotherapy waste reduction through shelf-life extension. Can J Hosp Pharm (1994) 1.29
Bayesian QTL analyses using pedigreed families of an outcrossing species, with application to fruit firmness in apple. Theor Appl Genet (2014) 1.27
Opportunity costs and uncertainty in the economic evaluation of health care interventions. Health Econ (2002) 1.25
Smad7 mediates apoptosis induced by transforming growth factor beta in prostatic carcinoma cells. Curr Biol (2000) 1.23
Healthy-years equivalents versus quality-adjusted life years: in pursuit of progress. Med Decis Making (1994) 1.21
Focus group interviews examining attitudes to randomised trials among breast cancer patients and the general community. Aust N Z J Public Health (1998) 1.21
Informed consent: what did the doctor say? Lancet (1999) 1.21
Characterising doctor-parent communication in counselling for impending preterm delivery. Arch Dis Child Fetal Neonatal Ed (2002) 1.21
Unitary components in the activation of Clarke's column neurones. Acta Physiol Scand (1969) 1.20
Cloning and expression of the gene coding for the transmission blocking target antigen Pfs48/45 of Plasmodium falciparum. Mol Biochem Parasitol (1993) 1.20
Informing breast cancer patients about clinical trials: a randomized clinical trial of an educational booklet. Ann Oncol (2002) 1.19